A dialysis facility in TX. It ran an operating loss of 27.9% in FY23 on $0.6M of operating revenue. It held 4 days of cash on hand (16th percentile among dialysis facilities on liquidity). Only a single comparable reporting year is available, so trend context is limited.
Operating margin · FY23
-27.9%
vs dialysis facilities7th pctl of 7,741
Days cash on hand · FY23
4d
all sources
vs dialysis facilities16th pctl
Total operating revenue · FY23
$0.6M
vs dialysis facilities5th pctl
Total margin · incl. nonoperating · FY23
-27.9%
vs dialysis facilities7th pctl
Where DIALYSIS 452878 sits among dialysis facilities
Operating margin · FY23 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 452878dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
-27.9% (FY23)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
-27.9% (FY23)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
4d (FY23)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
0.58× (FY23)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
83% (FY23)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
9d (FY23)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY21
FY22
FY23
Patient revenue
1,737
1,626
560
Total operating revenue
1,737
1,626
560
Total operating expenses
1,717
1,759
716
Operating income
21
(132)
(156)
Operating margin %
+1.2%
-8.1%
-27.9%
Other non-operating, net
0
0
0
Net income
21
(132)
(156)
Net income %
+1.2%
-8.1%
-27.9%
HCRIS CMS-265 cost report · $ thousands · FY20–FY23 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Total treatments
1,892
Verified fact2023
HCRIS CMS-265
Cost per treatment ($)
378.63
Verified fact2023
HCRIS CMS-265
Net revenue per treatment ($)
296.12
Verified fact2023
HCRIS CMS-265
Trajectory
Cost-report basis · 4 reporting years
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, TX
Median household income
$55.2K
vs $82.1K US · $59.7K rural median
Poverty rate
21.8%
vs 12.5% US · 14.3% rural median
Uninsured
17.9%
vs 8.6% US · 8.4% rural median
Age 65+
17.9%
vs 16.8% US · 20.6% rural median
Fair or poor health
27.6%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 14.5% of county personal income is Medicare/Medicaid medical benefits; 28.4% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
